August 31, 2014 4:59 AM ET


Company Overview of Archemix Corp.

Company Overview

Archemix Corp., a biotechnology company, discovers, develops, and commercializes therapeutic aptamers for the prevention and treatment of chronic and acute diseases in Massachusetts. Its aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases. Archemix Corp. was incorporated in 2000 and is based in Cambridge, Massachusetts.

148 Sidney Street

Cambridge, MA 02139

United States

Founded in 2000

79 Employees





Key Executives for Archemix Corp.

Co-Founder and Chief Technology Officer
Co-Founder and Vice President of Biology
Age: 55
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cellerant Therapeutics, Inc. United States
Catalyst Biosciences, Inc. United States
SpringLeaf Therapeutics, Inc. United States
Center Of Research Technology & Entrepreneurial Expertise United States
Meryx Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Archemix Corp., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at